Francis F. Brinholi

Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson’s disease and its progression: Disease and staging biomarkers and new drug targets

Carine Coneglian de Farias, Michaël Maes, Kamila Landucci Bonifácio et al. · Neuroscience Letters · 2016 · 128 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models

Francis F. Brinholi, Carine Coneglian de Farias, Kamila Landucci Bonifácio et al. · Biomedicine & Pharmacotherapy · 2016 · 70 citations

Medicine, Pharmacology, Pharmacotherapy +11

Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis

Francis F. Brinholi, Cristiano Noto, Michaël Maes et al. · Schizophrenia Research · 2015 · 37 citations

Medicine, Pharmacology, Psychiatry +5

Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways

Carine Coneglian de Farias, Michaël Maes, Kamila Landucci Bonifácio et al. · CNS & Neurological Disorders - Drug Targets · 2017 · 34 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Increased malondialdehyde and nitric oxide formation, lowered total radical trapping capacity coupled with psychological stressors are strongly associated with the phenome of first-episode mild depression in undergraduate students

Francis F. Brinholi, Asara Vasupanrajit, Laura de Oliveira Semeão et al. · Neuroscience · 2024 · 13 citations

Social Sciences, Psychiatry, Psychology +13